文献速递创伤与烧伤重症综合管理与镇静镇痛

急性中重度创伤性脑损伤患者贫血的发生率及相关因素

Incidence and Associated Factors of Anemia in Patients with Acute Moderate and Severe Traumatic Brain Injury.
PubMed 文献 · Neurocrit Care · 2022-08-02
一句话结论中重度创伤性脑损伤后48小时内重度贫血(血红蛋白<100 g/L)发生率达45.5%,颅外创伤与中线移位是独立相关因素。

这项回顾性队列研究纳入2010年8月至2012年7月Tampere大学医院急诊科收治的145例成人中重度创伤性脑损伤患者,重度贫血定义为血红蛋白<100 g/L。66例(45.5%)发生重度贫血,均出现在伤后48小时内。单因素分析显示女性、伤前抗血栓药物、心血管合并症、糖尿病、颅外创伤及初始头颅CT中线移位与贫血相关;多因素分析中仅中线移位(OR 2.26,95%CI 1.05-4.48)和颅外创伤(OR 4.71,95%CI 1.74-12.73)与重度贫血独立相关。提示对具备这些因素的中重度创伤性脑损伤患者应关注早期血红蛋白变化。

要点

  • 145例中重度创伤性脑损伤患者中66例(45.5%)发生重度贫血(血红蛋白<100 g/L),均于伤后48小时内出现。
  • 多因素分析中,颅外创伤与重度贫血独立相关(OR 4.71;95%CI 1.74-12.73)。
  • 多因素分析中,初始头颅CT中线移位与重度贫血独立相关(OR 2.26;95%CI 1.05-4.48)。
  • 单因素分析中女性(OR 2.84;95%CI 1.13-7.15)、伤前抗血栓药物(OR 3.33;95%CI 1.34-8.27)、心血管合并症(OR 3.12;95%CI 1.56-6.25)、糖尿病(OR 4.56;95%CI 1.69-12.32)与贫血相关。

适用人群与场景

  • 成人中重度创伤性脑损伤患者,收治于Tampere大学医院急诊科(2010年8月至2012年7月)。

诊断标准与关键阈值

  • 重度贫血定义为血红蛋白水平低于100 g/L。

研究设计与关键结果

  • 回顾性队列研究,纳入145例中重度创伤性脑损伤患者(男性83.4%,平均年龄55.0岁)。
  • 66例(45.5%)检测到重度贫血(血红蛋白<100 g/L),均发生于伤后48小时内。
  • 单因素分析:女性OR 2.84(95%CI 1.13-7.15);伤前抗血栓药物OR 3.33(95%CI 1.34-8.27);心血管合并症OR 3.12(95%CI 1.56-6.25);糖尿病OR 4.56(95%CI 1.69-12.32);颅外创伤OR 3.14(95%CI 1.69-12.32);初始头颅CT中线移位OR 2.03(95%CI 1.03-4.01)。
  • 多因素分析:中线移位OR 2.26(95%CI 1.05-4.48);颅外创伤OR 4.71(95%CI 1.74-12.73)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,中重度创伤性脑损伤后重度贫血常见,颅外创伤和初始头颅CT中线移位可能是贫血的相关因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Anemia might contribute to the development of secondary injury in patients with acute traumatic brain injury (TBI). Potential determinants of anemia are still poorly acknowledged, and reported incidence of declined hemoglobin concentration varies widely between different studies. The aim of this study was to investigate the incidence of severe anemia among patients with moderate to severe TBI and to evaluate patient- and trauma-related factors that might be associated with the development of anemia.

METHODS: This retrospective cohort study involved all adult patients admitted to Tampere University Hospital's emergency department for moderate to severe TBI (August 2010 to July 2012). Detailed information on patient demographics and trauma characteristics were obtained, including data on posttraumatic care, data on neurosurgical procedures, and all measured in-hospital hemoglobin values. Severe anemia was defined as a hemoglobin level less than 100 g/L. Both univariate and multivariable analyses were performed, and hemoglobin trajectories were created.

RESULTS: The study included 145 patients with moderate to severe TBI (male 83.4%, mean age 55.0 years). Severe anemia, with a hemoglobin level less than 100 g/L, was detected in 66 patients (45.5%) and developed during the first 48 h after the trauma. In the univariate analysis, anemia was more common among women (odds ratio [OR] 2.84; 95% confidence interval [CI] 1.13-7.15), patients with antithrombotic medication prior to trauma (OR 3.33; 95% CI 1.34-8.27), patients with cardiovascular comorbidities (OR 3.12; 95% CI 1.56-6.25), patients with diabetes (OR 4.56; 95% CI 1.69-12.32), patients with extracranial injuries (OR 3.14; 95% CI 1.69-12.32), and patients with midline shift on primary head computed tomography (OR 2.03; 95% CI 1.03-4.01). In the multivariable analysis, midline shift and extracranial traumas were associated with the development of severe anemia (OR 2.26 [95% CI 1.05-4.48] and OR 4.71 [95% CI 1.74-12.73], respectively).

CONCLUSIONS: Severe anemia is common after acute moderate to severe TBI, developing during the first 48 h after the trauma. Possible anemia-associated factors include extracranial traumas and midline shift on initial head computed tomography.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Vanhala H, Junttila E, Kataja A, et al. Incidence and Associated Factors of Anemia in Patients with Acute Moderate and Severe Traumatic Brain Injury. Neurocrit Care. 2022. PMID: 35915348. doi:10.1007/s12028-022-01561-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。